M. Torgutalp Et Al. , "Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels," Mediterranean Journal of Rheumatology , vol.32, no.1, pp.56-65, 2021
Torgutalp, M. Et Al. 2021. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels. Mediterranean Journal of Rheumatology , vol.32, no.1 , 56-65.
Torgutalp, M., Yayla, M. E., Eroglu, D. S., Dincer, A. B. K., Yurteri, E., Okatan, I. E., ... Sezer, S.(2021). Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels. Mediterranean Journal of Rheumatology , vol.32, no.1, 56-65.
Torgutalp, Murat Et Al. "Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels," Mediterranean Journal of Rheumatology , vol.32, no.1, 56-65, 2021
Torgutalp, Murat Et Al. "Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels." Mediterranean Journal of Rheumatology , vol.32, no.1, pp.56-65, 2021
Torgutalp, M. Et Al. (2021) . "Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels." Mediterranean Journal of Rheumatology , vol.32, no.1, pp.56-65.
@article{article, author={Murat Torgutalp Et Al. }, title={Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels}, journal={Mediterranean Journal of Rheumatology}, year=2021, pages={56-65} }